Fed Regist. 2012 Apr 12;77(71):22072-175.
This final rule with comment period revises the Medicare Advantage (MA) program (Part C) regulations and prescription drug benefit program (Part D) regulations to implement new statutory requirements; strengthen beneficiary protections; exclude plan participants that perform poorly; improve program efficiencies; and clarify program requirements. It also responds to public comments regarding the long-term care facility conditions of participation pertaining to pharmacy services.
本带有意见征求期的最终规则修订了医疗保险优势(MA)计划(C部分)法规和处方药福利计划(D部分)法规,以实施新的法定要求;加强对受益人的保护;排除表现不佳的计划参与者;提高计划效率;并澄清计划要求。它还回应了关于长期护理机构药房服务参与条件的公众意见。